{"id":"menopur-inj","safety":{"commonSideEffects":[{"rate":null,"effect":"Ovarian hyperstimulation syndrome (OHSS)"},{"rate":null,"effect":"Headache"},{"rate":null,"effect":"Injection site reactions"},{"rate":null,"effect":"Abdominal pain/bloating"},{"rate":null,"effect":"Nausea"}]},"_chembl":{"chemblId":"CHEMBL2108427","moleculeType":"Protein"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Menopur contains equal amounts of FSH and LH extracted from the urine of postmenopausal women. FSH directly stimulates the growth and maturation of ovarian follicles, while LH supports steroidogenesis and follicle maturation. Together, these hormones promote the development of multiple follicles for assisted reproductive procedures.","oneSentence":"Menopur is a purified preparation of human menopausal gonadotropins (hMG) containing follicle-stimulating hormone (FSH) and luteinizing hormone (LH) that stimulates ovarian follicle development and hormone production in women undergoing fertility treatment.","_ai_confidence":"high"},"_scrapedAt":"2026-03-27T23:54:21.282Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Ovulation induction in anovulatory women"},{"name":"Controlled ovarian hyperstimulation in assisted reproductive technology (ART) cycles"},{"name":"Spermatogenesis stimulation in hypogonadal men"}]},"trialDetails":[{"nctId":"NCT02458768","phase":"PHASE4","title":"Multicenter, Randomized, Open Label, Parallel Study to Evaluate the Efficacy & Safety of IVF-M HP Inj. vs. Menopur® Inj.","status":"COMPLETED","sponsor":"LG Life Sciences","startDate":"2013-07","conditions":"Infertility, Female","enrollment":112}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":4,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"Menopur® Inj.","genericName":"Menopur® Inj.","companyName":"LG Life Sciences","companyId":"lg-life-sciences","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Menopur Inj. is a medication used to treat female infertility, specifically as part of in vitro fertilization (IVF) treatment. It works by acting as an agonist to the lutropin-choriogonadotropic hormone receptor, stimulating the production of luteinizing hormone and follicle-stimulating hormone.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}